Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.

Source:http://linkedlifedata.com/resource/pubmed/id/17785622

Circulation 2007 Oct 2 116 14 1577-84

Download in:

View as

General Info

PMID
17785622